Fixing Commercial Alignment in B2B Life Science Marketing

In most B2B life science companies, marketing does not sit at the executive table as an independent function. Whether selling mass spectrometers, cell culture media, or CDMO capacity, marketing almost always reports up through a VP of Commercial, a Chief Revenue Officer, or directly to Sales leadership.

On paper, this structure should force alignment. In practice, it frequently turns marketing into an internal service bureau. Instead of shaping commercial strategy and generating qualified pipeline, marketing teams get trapped in a reactive loop of designing trade show banners, updating sales decks, and formatting product datasheets.

McKinsey & Company's research on executive alignment highlights the cost of this structural disconnect. While their study examines the CEO-CMO dynamic, the underlying mechanics apply directly to executive commercial leaders and their marketing heads in life sciences. When commercial leadership and marketing are aligned on strategy and scope, performance accelerates dramatically. When they are disconnected, marketing spending turns into overhead rather than a growth engine.

Here is what the McKinsey findings mean for life science commercial leaders, and how to fix the dynamic.

1. High-Growth Companies Treat Marketing as a Commercial Partner, Not a Support Function

McKinsey found that companies with high CEO-CMO alignment are twice as likely to achieve above-peer revenue growth compared to those where marketing operates in isolation or strictly as an execution arm.

In B2B life sciences, marketing is too often managed as an admin expense rather than a revenue lever. When a VP of Commercial views marketing primarily as sales enablement, the department's priorities shift toward tactical activity metrics: trade shows attended, brochures printed, and webinars scheduled. None of these metrics capture whether scientific buyers are moving through a conversion funnel or developing a preference for your brand.

To capture the growth premium identified in McKinsey's research, commercial leaders must redefine marketing's mandate. Marketing's primary job is not to serve the sales team; its job is to understand scientific buyer intent, establish market positioning, and generate predictable pipeline. When marketing is involved in shaping commercial strategy, sales teams inherit better-qualified leads and shorter deal cycles.

2. The Mandate Disconnect Is Real — and Costly

One of the most striking findings in McKinsey's study is a persistent perception gap: while 90 percent of CEOs believe they have clearly communicated marketing's mandate, only 50 percent of CMOs feel they have a clear directive from leadership.

In life science organizations, this gap is usually wider. Commercial executives assume marketing knows its objectives ("drive leads for the new flow cytometer"), but fail to provide the strategic context required to execute effectively. Marketing ends up guessing which buyer personas matter, which technical differentiators to emphasize, and how target accounts are defined.

The consequence is predictable: marketing launches broad awareness campaigns that fail to resonate with principal investigators or procurement managers, while sales complains that incoming leads are unvetted and useless.

Closing this gap requires explicit definitions. Commercial leadership and marketing must explicitly agree on three operational boundaries:

• Ideal Customer Profile (ICP): The exact institutional tier, lab type, budget authority, and scientific application targeted.
• Qualified Lead Definitions: Clear, quantifiable criteria for what constitutes a Marketing Qualified Lead (MQL) and a Sales Accepted Lead (SAL).
• Revenue Attribution: Agreed-upon metrics for how marketing touchpoints contribute to total pipeline value.

3. High Performers Focus on Full-Funnel Value

McKinsey's research notes that high-performing organizations align marketing activities directly across the entire customer lifecycle, rather than siloing marketing at the top of the funnel and sales at the bottom.

Scientific purchasing decisions are rarely linear. A technical director at a biotech firm evaluating a automated liquid handler might read a white paper, consult peers, request a trial dataset, and attend a technical presentation over six to twelve months. If marketing drops off after capturing an email address, or if sales intervenes without knowing what technical documentation the prospect has already reviewed, the opportunity stalls.

Commercial leaders must integrate marketing into the entire buyer journey. Effective demand generation requires continuous, technically accurate messaging that supports prospects from initial discovery through technical evaluation and procurement.

A Checklist for Commercial and Marketing Alignment

To move your commercial organization onto the same page, step back from daily execution and audit your operational alignment against this baseline:

• [ ] Shared Metric Accountability: Does marketing share responsibility for pipeline volume and revenue targets, or are they measured solely on vanity metrics like clicks and trade show scans?
• [ ] Unified Scientific Positioning: Have sales and marketing agreed on a single, defensible positioning strategy that addresses real lab pain points, or is sales pitching features that contradict marketing collateral?
• [ ] Bi-Directional Feedback Loops: Is there a formal weekly or bi-weekly review where sales provides direct feedback on lead quality and marketing shares content consumption trends?
• [ ] Clear Handoff SLA: Is there an explicit Service Level Agreement (SLA) dictating how quickly sales must follow up on qualified leads, and when leads return to marketing for nurturing?
• [ ] Joint Campaign Planning: Are marketing launches designed around actual sales rep capacity and target account lists, rather than arbitrary trade show calendar dates?
• [ ] Shared IT: Are your marketing activities and data integrated into the same IT systems used by sales and finance, or siloed into their own system?

Aligning sales and marketing is not a team-building exercise; it is an operational discipline. When life science commercial leaders treat marketing as a strategic peer responsible for revenue, commercial efficiency improves across the entire organization.

Ready to align your executive leadership and turn your marketing team into a growth engine? Contact our team at BioBM.